AZTA Azenta, Inc.

35.89USD-8.79%Mkt Cap: 1.57B $P/E: —

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and int…

Key Statistics

Company
Market Cap1.57B USD
Enterprise Value1.45B USD
Revenue (TTM)613.81M USD
Gross Profit270.28M USD
Net Income (TTM)-55.76M USD
Revenue/Share13.41 USD
Last Price35.89 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees2.9K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)66.98
PEG0.53
EV/EBITDA43.99
EV/Revenue2.37
P/S2.81
P/B1.14
EPS (TTM)-2.47
EPS (Forward)0.59
52W Range
15.9366% of range46.40
52W High46.40 USD
52W Low15.93 USD
Profitability
Gross Margin45.52%
Oper. Margin-2.27%
EBITDA Margin5.38%
Profit Margin-9.39%
ROE-3.23%
ROA-2.71%
Growth
Revenue Growth12.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF72.18M USD
CapEx (TTM)33.86M USD
FCF Margin10.32%
FCF Yield4.03%
Net Debt-271.83M USD
Net Debt/EBITDA-8.24
Balance Sheet
Debt/Equity0.03
Current Ratio2.50
Quick Ratio1.85
Book Value/Sh34.51 USD
Cash/Share7.44 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield1.05%
Payout Ratio0.00%
Ex-Div DateDec 2, 2021
Pay DateDec 23, 2021
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)37.00 USD
Upside (mean)+3.1%
Target Range33.00 USD – 42.00 USD
33.00+3.1% to mean42.00
# Analysts4
Ownership
Shares Out.43.81M
Float38.88M
Insiders1.34%
Institutions117.35%
Short Interest
Short Ratio6.6d
Short % Float19.95%
Short % Out.12.29%
Shares Short5.38M
Short (prev mo.)5.25M
Technical
SMA 5033.07 (+8.5%)
SMA 20028.24 (+27.1%)
Beta1.52
S&P 52W Chg16.45%
Avg Vol (30d)1.06M
Avg Vol (10d)1.42M
Technical Indicators
RSI (14)54.1
MACD1.7742
MACD Signal1.3773
MACD Hist.+0.3969
BB Upper40.52 USD
BB Middle34.26 USD
BB Lower28.01 USD
BB Width36.50%
ATR (14)2.356 USD
Vol Ratio (20d)1.48x